| Stage | DLX | % of rev | DMC | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $499M | 100.00% | $1.1B | 100.00% | DMC ×2.19 |
| Gross profit | $260M | 51.99% | $103M | 9.37% | DLX +42.6pp |
| Operating income | $56M | 11.16% | $29M | 2.66% | DLX +8.5pp |
| Pre-tax income | $30M | 6.03% | $26M | 2.36% | DLX +3.7pp |
| Net income | $19M | 3.85% | $19M | 1.71% | DLX +2.1pp |
| Stage | DLX | DMC | Gap · A − B |
|---|---|---|---|
| Revenue | $499M100.00% | $1.1B100.00% | DMC ×2.19 |
| Gross profit | 51.99%$260M | 9.37%$103M | DLX +42.6pp |
| Operating income | 11.16%$56M | 2.66%$29M | DLX +8.5pp |
| Pre-tax income | 6.03%$30M | 2.36%$26M | DLX +3.7pp |
| Net income |
| 3.85%$19M |
| 1.71%$19M |
| DLX +2.1pp |
No shared counterparties.